We previously described the negative direct effects of TGF-β1 treatment on BK activity and ASL volume in cells from cystic fibrosis patients, an effect mediated via downregulation of the BK γ subunit LRRC2611. This evidence concerns the gene TGFB1 and cystic fibrosis.